Amazon One Medical starts nationwide GLP-1 program with cash prices from $149 a month

Amazon One Medical opened a nationwide GLP-1 treatment program on April 21, 2026, combining primary care visits with prescription fulfillment through Amazon Pharmacy ^[1][2].

The advertised prices put insured patients as low as $25 a month for medication. People paying without insurance are quoted $149 a month for oral GLP-1 pills and $299 a month for injectables such as Wegovy or Zepbound ^[1][2]. CNBC reported those cash figures sit close to what much of the market already charges ^[1]. A review site that scores GLP-1 providers, and discloses that it earns commissions on some signups, described $299 as the lowest cash-pay injectable price among the platforms it has evaluated ^[3].

Delivery is central to the pitch. Amazon Pharmacy ships to all 50 states, offers same-day service in roughly 3,000 cities and towns, and says it intends to reach about 4,500 cities by the end of 2026 ^[1][2][3].

Everything on the medication list is brand-name. It runs to Wegovy (semaglutide) in daily pill and weekly injection forms, Zepbound (tirzepatide) as a single-dose auto-injector and as a multi-dose KwikPen, and Foundayo (orforglipron) as a daily pill, which won approval on April 1, 2026 ^[2][3]. Compounded versions are not offered ^[3].

Amazon frames the clinical side as chronic-disease care. Patients are screened before a first appointment, then seen in structured consultations with standardized documentation and safety protocols ^[2]. Because GLP-1 medicines can shift blood pressure and A1C readings, the program's clinicians adjust patients' existing hypertension and diabetes prescriptions as weight comes down ^[2].

"Obesity affects more than 40% of U.S. adults, and while advances such as GLP-1-based therapies are helping... without long-term care and clinical guidance, patients can experience negative impacts to their overall health," said Dr. Hemalee Patel, senior medical director of cardiometabolic health at One Medical ^[2].

Tanvi Patel, vice president and general manager of Amazon Pharmacy, said the company is "making it easier for customers to get the treatments their healthcare providers prescribe and to stay on those medications because they are delivered reliably directly to patients" ^[1].

There are costs the medication price does not cover. One Medical charges a membership fee of about $199 a year for Prime members and about $299 a year for everyone else, and insurance does not pay it; the review site calculates the Prime rate at roughly $17 a month ^[3]. Getting a new GLP-1 prescription means already being a One Medical primary care patient, though people who have a prescription from another provider can arrange renewals through a $29 message consultation or a $49 video visit ^[3]. Those visits do not include writing a new prescription ^[3]. The practice has more than 200 offices in 20-plus cities plus virtual care nationwide ^[3], and the program does not include behavioral coaching, a cognitive behavioral therapy curriculum or a registered dietitian, according to the review ^[3].

Manufacturer savings cards from Novo Nordisk and Eli Lilly are applied automatically when patients check out, a program Amazon Pharmacy says has saved customers more than $200 million, with GLP-1 drugs the biggest category ^[2].

Investors read the announcement as a competitive threat. Shares of Hims & Hers Health, Viking Therapeutics, Amgen and Septerna traded lower after it landed ^[1]; the review site recorded a 6% drop for Hims & Hers that day ^[3].

Why it matters for patients

The insured figure of $25 a month, and $149 to $299 without insurance, is competitive with what other services quote ^[1][3]. Automatic coupon application removes a step that elsewhere falls to the patient ^[3]. People already taking a GLP-1 through another provider can move refills to Amazon Pharmacy instead of starting over, as long as they understand the renewal pathway is not a new prescription ^[3].

The limits matter too. The membership fee sits outside insurance coverage ^[3], in-person care reaches only about 20 metro areas, and patients elsewhere depend on mail delivery ^[3]. Amazon has not published data on how well patients do in the program.

What happens next

Amazon says same-day pharmacy delivery should reach roughly 4,500 cities by the end of this year ^[1][2]. Enrollment totals, appointment wait times and any clinical outcome data have not been disclosed, and the review site notes there are no results yet to compare against other programs ^[3].